Literature DB >> 9616756

Effect of Maitake D-fraction on cancer prevention.

H Nanba1, K Kubo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9616756     DOI: 10.1111/j.1749-6632.1997.tb48611.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

Review 1.  Proteomic Research on the Antitumor Properties of Medicinal Mushrooms.

Authors:  Boris Jakopovic; Nada Oršolić; Ivan Jakopovich
Journal:  Molecules       Date:  2021-11-05       Impact factor: 4.411

Review 2.  Mushroom Polysaccharide-Assisted Anticarcinogenic Mycotherapy: Reviewing Its Clinical Trials.

Authors:  Iyyakkannu Sivanesan; Manikandan Muthu; Judy Gopal; Jae-Wook Oh
Journal:  Molecules       Date:  2022-06-25       Impact factor: 4.927

3.  Synergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapy.

Authors:  Sensuke Konno
Journal:  Int J Gen Med       Date:  2009-07-30

Review 4.  Immunomodulatory dietary polysaccharides: a systematic review of the literature.

Authors:  Jane E Ramberg; Erika D Nelson; Robert A Sinnott
Journal:  Nutr J       Date:  2010-11-18       Impact factor: 3.271

5.  Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP).

Authors:  Tze-chen Hsieh; Peili Wu; Spencer Park; Joseph M Wu
Journal:  BMC Complement Altern Med       Date:  2006-09-11       Impact factor: 3.659

6.  Mushroom β-Glucan May Immunomodulate the Tumor-Associated Macrophages in the Lewis Lung Carcinoma.

Authors:  Wan-Jhen Wang; Yu-Sheng Wu; Sherwin Chen; Chi-Feng Liu; Shiu-Nan Chen
Journal:  Biomed Res Int       Date:  2015-06-17       Impact factor: 3.411

7.  Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.

Authors:  Agustina Roldan-Deamicis; Eliana Alonso; Belén Brie; Diego Aguilera Braico; Gabriela Andrea Balogh
Journal:  Cancer Med       Date:  2016-07-11       Impact factor: 4.452

8.  Ganoderma lucidum beta 1,3/1,6 glucan as an immunomodulator in inflammation induced by a high-cholesterol diet.

Authors:  Yu-Sheng Wu; Shu-Ying Ho; Fan-Hua Nan; Shiu-Nan Chen
Journal:  BMC Complement Altern Med       Date:  2016-12-03       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.